文献速递卫生政策与健康促进免疫规划

在卫生技术评估与卫生经济学中捕捉疫苗接种的价值:文献综述与新型概念框架

Capturing the value of vaccination within health technology assessment and health economics: Literature review and novel conceptual framework.
PubMed 文献 · Vaccine · 2022-05-23

该分析聚焦卫生技术评估系统,通过文献综述识别与非大流行疫苗经济评估相关的价值概念,并由发达国家疫苗经济学专家开发出疫苗接种价值(VoV)框架。共纳入44项研究,识别并定义18个独特价值概念,按支付者视角到社会视角分为三个维度。维度I和II有良好证据支持,维度III需进一步工作生成证据。

要点

  • 共纳入44项研究,识别并定义18个与非大流行疫苗经济评估相关的独特价值概念。
  • VoV框架将价值概念分为三个维度:常规支付者视角、常规社会视角和新型社会视角。
  • 维度I和II有良好质量证据和方法支持,维度III需进一步工作生成所需证据。

核心结论

  • VoV框架与考虑经济评估的政策决策尤其相关,并有助于未来扩展非大流行疫苗价值考量。
  • 该框架帮助理解和比较各国当前价值考量及支付者与社会视角的差异,为决策者提供透明且逻辑的路径以拓宽经济评估中的VoV考量。

研究设计与样本

  • 文献综述后,由来自已建立卫生技术评估系统的发达国家的疫苗经济评估专家开发新型VoV框架。
  • 共纳入44项呈现适用于疫苗接种的价值框架或概念的研究。

主要发现

  • 识别并定义18个与经济评估相关的独特价值概念,并在VoV框架中按三个维度分类。
  • 维度I为常规支付者视角概念(如疫苗接种者的健康收益、直接医疗成本)。
  • 维度II为常规社会视角概念(如照护者/家庭的间接健康/经济收益、疫苗接种者的生产力)。
  • 维度III为新型社会概念(如财务风险保护、安心、社会健康收益、卫生系统安全、政治稳定、社会公平和宏观经济收益)。
  • 维度I和II有良好质量证据和方法支持,维度III需进一步工作生成疫苗接种影响所需的证据。

临床怎么用

  • 作者认为VoV框架与考虑经济评估的政策决策尤其相关,并有助于未来扩展非大流行疫苗价值考量。
  • 作者认为该框架可帮助理解和比较各国当前价值考量及支付者与社会视角的差异,并为决策者提供透明且逻辑的路径以拓宽经济评估中的VoV考量。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Vaccination provides significant health gains to individuals and society and can potentially improve health equity, healthcare systems and national economies. Policy decisions, however, are rarely informed by comprehensive economic evaluations (EE) including vaccination's wide-ranging value. The objective of this analysis was to focus on health technology assessment systems to identify relevant value concepts in order to improve current EE of non-pandemic vaccines. METHODS: Following a literature review, a novel Value of Vaccination (VoV) framework was developed with experts in vaccine EE from developed countries with established health technology assessment systems. RESULTS: Forty-four studies presenting value frameworks or concepts applicable to vaccination were included. Eighteen unique value concepts relevant to EE were identified and defined. These were categorised within the VoV framework using three dimensions, moving from a narrow payer perspective to a more expansive and societal perspective. The dimensions were: (I) conventional payer perspective concepts (e.g., health gains in vaccinees, direct medical costs); (II) conventional societal perspective concepts (e.g., indirect health/economic gains to caregivers/households, productivity in vaccinees); and (III) novel societal concepts (e.g., financial risk protection, peace of mind, societal health gains, healthcare systems security, political stability, social equity and macroeconomic gains). While good quality evidence and methods are available to support concepts in Dimensions I and II, further work is needed to generate the required evidence for vaccination impact on Dimension III concepts. CONCLUSIONS: The devastating effect on nations of the COVID-19 pandemic has helped to highlight the potential far-reaching benefits that many vaccination programmes can offer. This VoV framework is particularly relevant to policy decisions considering EE, and the potential future expansion of non-pandemic vaccination value considerations. The framework helps to understand and compare current value considerations across countries and payer versus societal perspectives. It provides decision-makers with a transparent and logical path to broaden consideration of VoV in EE.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Beck E, Biundo E, Devlin N, et al. Capturing the value of vaccination within health technology assessment and health economics: Literature review and novel conceptual framework. Vaccine. 2022. PMID: 35618559. doi:10.1016/j.vaccine.2022.04.050

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。